Recombinant multi-species CCL18/MIP-4 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CCL18/MIP-4 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This antimicrobial gene is one of several Cys-Cys (CC) cytokine genes clustered on the q arm of chromosome 17. Cytokines are a family of secreted proteins involved in immunoregulatory and inflammatory processes. The CC cytokines are proteins characterized by two adjacent cysteines. The cytokine encoded by this gene displays chemotactic activity for naive T cells, CD4+ and CD8+ T cells and nonactivated lymphocytes, but not for monocytes or granulocytes. This chemokine attracts naive T lymphocytes toward dendritic cells and activated macrophages in lymph nodes. It may play a role in both humoral and cell-mediated immunity responses. [provided by RefSeq, Sep 2014]
The Alternative Names of target: AMAC-1,AMAC1,Alternative macrophage activation-associated CC chemokine 1 (AMAC-1),C-C motif chemokine 18,CC chemokine PARC,CCL18,CKb7,DC-CK1,DCCK1,Dendritic cell chemokine 1 (DC-CK1),MIP-4,Macrophage inflammatory protein 4 (MIP-4),PARC,Pulmonary and activation-regulated chemokine,SCYA18,Small-inducible cytokine A18

Target products collectionGo to CCL18/MIP-4 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE0743-Ag-1/ GM-Tg-hg-SE0743-Ag-2 Human CCL18/MIP-4 protein Human
GM-Tg-rg-SE0743-Ag-1/ GM-Tg-rg-SE0743-Ag-2 Rat CCL18/MIP-4 protein Rat
GM-Tg-mg-SE0743-Ag-1/ GM-Tg-mg-SE0743-Ag-2 Mouse CCL18/MIP-4 protein Mouse
GM-Tg-cynog-SE0743-Ag-1/ GM-Tg-cynog-SE0743-Ag-2 Cynomolgus/Rhesus macaque CCL18/MIP-4 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE0743-Ag-1/ GM-Tg-felg-SE0743-Ag-2 Feline CCL18/MIP-4 protein Feline
GM-Tg-cang-SE0743-Ag-1/ GM-Tg-cang-SE0743-Ag-2 Canine CCL18/MIP-4 protein Canine
GM-Tg-bovg-SE0743-Ag-1/ GM-Tg-bovg-SE0743-Ag-2 Bovine CCL18/MIP-4 protein Bovine
GM-Tg-equg-SE0743-Ag-1/ GM-Tg-equg-SE0743-Ag-2 Equine CCL18/MIP-4 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE0743-Ag-1/ GM-Tg-hg-SE0743-Ag-2; GM-Tg-rg-SE0743-Ag-1/ GM-Tg-rg-SE0743-Ag-2;
GM-Tg-mg-SE0743-Ag-1/ GM-Tg-mg-SE0743-Ag-2; GM-Tg-cynog-SE0743-Ag-1/ GM-Tg-cynog-SE0743-Ag-2;
GM-Tg-felg-SE0743-Ag-1/ GM-Tg-felg-SE0743-Ag-2; GM-Tg-cang-SE0743-Ag-1/ GM-Tg-cang-SE0743-Ag-2;
GM-Tg-bovg-SE0743-Ag-1/ GM-Tg-bovg-SE0743-Ag-2; GM-Tg-equg-SE0743-Ag-1/ GM-Tg-equg-SE0743-Ag-2
Products Name CCL18/MIP-4 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name CCL18/MIP-4
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CCL18/MIP-4 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.